SHU, CASSANDRA,ATLURI, HARISHA,KUEHL, ROBERT,TAY, PEARL SHWE-CHO,MINIKIS, RYAN MITCHELL,HULVAT, JAMES FRANCIS,MCVEY, ALEXANDER JACOB,CHONG, CHING WAH
申请号：
SG11201700849X
公开号：
SG11201700849XA
申请日:
2015.08.07
申请国别(地区):
SG
年份:
2017
代理人:
摘要：
Described herein is the Brutons tyrosine kinase (Btk) inhibitor 1-((R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one, including novel pharmaceutical formulations thereof. Also disclosed are pharmaceutical compositions that include the Btk inhibitor, as well as methods of using the Btk inhibitor, alone or in combination with other therapeutic agents, for the treatment of autoimmune diseases or conditions, heteroimmune diseases or conditions, cancer, including lymphoma, and inflammatory diseases or conditions.
